PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a randomized trial studying a new heart valve to treat aortic valve disorders.
River Health ACO, a partnership of PinnacleHealth System, Susquehanna Health and affiliates, has been selected to participate in the Centers for Medicare & Medicare Services (CMS) new accountable care organization (ACO) model called the Next Generation ACO Model (NGACO Model), advancing the Administration’s health care system goals and building on experience from the Pioneer ACO Model and the Medicare Shared Savings Program.
The not-for-profit PinnacleHealth Health System is launching the Space to Grow, Room to Heal donor campaign to add inpatient beds and services for children ages 4 to 12 at the Pennsylvania Psychiatric Institute (PPI).
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II clinical on October 19, 2015. This trial is to assess the safety and efficacy of a vascular implant for the treatment of dissections (tearing in the artery wall) that occur following balloon angioplasty (PTA) of the main artery in the leg.
PinnacleHealth CardioVascular Institute enrolled the first two patients in the United States in a randomized trial studying a heart valve to treat aortic valve disorders.
Three PinnacleHealth patients recently underwent a new procedure for aortic valve reconstruction using the patients’ own heart tissue (pericardium) to create the new valves. Aortic valve reconstruction patients benefit from using their own pericardial tissue as it has fewer tendencies to scar and calcify, which is the main reason for failure of tissue valves obtained from animals. The body also is less likely to mount an immune response against the patient’s own tissue. In addition, these patients do not need lifelong blood thinners, which are required when mechanical aortic valves are used.
PinnacleHealth enrolled the first patient nationally in a new clinical trial investigating a larger size of the Medtronic CoreValve® Evolut® R System—the Evolut R 34mm System.
PinnacleHealth team that participated in a three-year clinical trial designed to evaluate potential benefits of a first-of-its-kind drug eluting ABSORB Bioresorbable Vascular Scaffold (BVS), today announced it deployed the device for the first time after FDA approval for commercial use.
Pre-surgical clinic aims to improve patient satisfaction and overall health and to decrease surgical complications, readmissions, same-day surgery cancellations and hospital length of stay.
The U.S. News analysis of hospitals includes data from nearly 5,000 centers across multiple clinical specialties, procedures and conditions. Scores are based on a variety of patient outcome and care-related factors, such as patient safety and nurse staffing. Hospitals are ranked nationally in specialties and regionally in states and major metro areas. U.S. News assigns a rating to hospitals in a handful of common procedures and conditions, including hip replacement and COPD. This hospital achieved the highest rating possible in 9 procedures or conditions.
PinnacleHealth became the first hospital in the country to implant the EDWARDS INTUITY Elite valve, a rapid deployment device for surgical aortic valve replacement, after U.S. Food and Drug Administration (FDA) approval.
Hidden Scar is an advanced approach in which breast surgeons remove cancerous tissue through a single incision made in inconspicuous areas to minimize visible scarring. By using this approach, surgeons are able to preserve a natural-looking breast by sparing the nipple, areola and surrounding tissue.
Dr. Veytsman discusses the Human Papillomavirus (HPV) and the connection to head and neck cancers. January is National Cervical Cancer Awareness Month.
Drug overdose in the United States increased by seven percent in 2014 and accounted for a total of 47,055 deaths. According to the CDC, 61 percent of those deaths involved some type of opioid. The PinnacleHealth Medical Group reduced monthly average of prescriptions written for opioids by 20 percent.
The RECHORD trial allows cardiovascular surgeons to replace damaged string-like tendons, called chordae, through a small incision while the heart is beating. PinnacleHealth is one of only 20 sites in the nation and the only hospital in Pennsylvania selected to participate in the trial. Up to 450 patients will be enrolled into the randomized trial.
Through monitoring and dosing guidelines, provider education and training and better alternatives for patient pain management, medical group reduces monthly average of written pain medicine prescriptions by 20 percent, while the number of providers within the medical group grew by 22 percent and the number of patients grew by 12 percent.
The PinnacleHealth Breast Care Center has received three-year re-accreditation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. The NAPBC represents a consortium of national, professional organizations dedicated to setting the highest clinical targets for the quality of care and monitoring of outcomes of patients with diseases of the breast.
Vaccines are an important part of routine healthcare for adults, seniors and women who are pregnant. Older adults and seniors need protection against infectious illnesses just like children do. Dr. Cathleen Veach lists the four most important vaccines for adults.
Pennsylvania Health Care Cost Containment Council report shows successful decline in hospital-based mortality and readmissions for CABG and valve surgery in Pennsylvania.
PinnacleHealth CardioVascular Institute enrolled the first patient in the United States in a trial assessing the safety and effectiveness of a new type of approach for blockages in the leg artery. DISRUPT PAD III is the largest ever multi-center randomized study to exclusively enroll patients with calcified peripheral artery disease (PAD).
An international clinical trial, called REFLECT, studies the safety and efficacy of the Keystone Heart TriGuard™ cerebral embolic protection device to minimize the risk of cerebral damage during TAVR and other cardiovascular procedures.
PinnacleHealth CardioVascular Institute in Harrisburg, PA, enrolled the first patient in Pennsylvania in a trial assessing the safety and effectiveness of a new stent to treat patients with coronary heart disease who are at higher risk for bleeding.
PinnacleHealth acquired the da Vinci Xi® Surgical System, further complementing its hospitals’ minimally invasive robotic surgery capabilities and making the PinnacleHealth Robotics Institute the most extensive in central Pennsylvania. Robert Carman, Jr., DO, FACOS, general and colorectal surgeon, performed a minimally invasive inguinal hernia repair and a colon resection.
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology shown to help protect patients from the risk of stroke during transcatheter aortic valve replacement (TAVR).
Thomas R. Stoner, DO, FACOI, vice president, Hospitalist Services at PinnacleHealth, and sepsis physician champion for The Hospital and Healthsystem Association of Pennsylvania (HAP), will lead a day-long conference for health professionals, Raising the Bar for Sepsis Care in Pennsylvania. The conference will be September 6 at the Sheraton Harrisburg Hershey Hotel. Specialists from PinnacleHealth and across the state will share evidence-based protocols to improve sepsis care, bundle compliance, and reduce sepsis mortality and readmissions in Pennsylvania hospitals.
Numerous studies show that the more we sit and the less we move, the sicker we are. On the flip side, there are many studies that show that any amount of exercise is better than none, and that moving is associated with better health.
UPMC Pinnacle and Harristown Enterprises celebrated the opening of Strawberry Square FamilyCare with a ribbon cutting today. The new practice, located in Suite 165 on the first floor of the Strawberry Square complex, opens for patients Monday, Nov. 20.
Remember when your mom always told you “what you do now will catch up with you when you’re older?” She wasn’t lying. Lung cancer is a disease that mostly affects the elderly, with 83 percent of those living with cancer being 60-years-of-age or older, but reducing your risk of getting lung cancer starts when you’re young.